Jenburkt Pharmaceuticals Ltd
BSE:524731
Jenburkt Pharmaceuticals Ltd
BSE:524731
Price:
1 009.8
INR
0.36%
Market Closed
Market Cap:
₹4.5B
Relative Value
The Relative Value of one
JENBURPH
stock under the Base Case scenario is
411.72
INR.
Compared to the current market price of 1 009.8 INR,
Jenburkt Pharmaceuticals Ltd
is
Overvalued by 59%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
JENBURPH
Relative Value
Base Case
411.72
INR
Overvaluation 59%
Multiples Across Competitors
JENBURPH Competitors Multiples
Jenburkt Pharmaceuticals Ltd Competitors
Jenburkt Pharmaceuticals Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Jenburkt Pharmaceuticals Ltd
BSE:524731
|
4.5B INR | 2.7 | 13.7 | 10.8 | 11.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
866.9B USD | 13.3 | 42 | 28.4 | 30.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
572.1B USD | 6.1 | 21.3 | 14.8 | 18.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
219.1B GBP | 5 | 28.6 | 15.8 | 22.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
225.5B CHF | 5.2 | 20.8 | 12.9 | 16.5 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
282.6B USD | 4.3 | 15.5 | 9.6 | 11.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
240.1B USD | 103.6 | -82.1 | 380.1 | 953.2 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.1 | 7.5 | 8.8 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.9B USD | 2.5 | 20.1 | 7.7 | 10.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117B USD | 2.4 | 16.6 | 7 | 8.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
